Clinical Trial Update: Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic study assessing two doses of ATV/r once daily plus two NRTIs in Thai HIV-1 infected patients; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• HIV Infections

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)
• NRTIs (two nucleoside reverse transcriptase inhibitors) (nucleoside reverse transcriptase inhibitors)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED